Abstract
A proliferation-inducing ligand (APRIL) is a new tumor necrosis factor family member implicated in tumor cell proliferation. We investigated the role of APRIL in megakaryocytopoiesis, a developmental hematopoietic process responsible for progenitor cell differentiation to megakaryoblasts and megakaryocytes, leading to platelet formation. APRIL is not expressed in CD34+ progenitor cells from healthy donors, but it is massively up-regulated during the proliferative phase of megakaryocytic cell differentiation. Exogenous APRIL expression in primary cells increases megakaryocytic cell growth, suggesting that APRIL acts as a proliferative factor in megakaryocytopoiesis. More importantly, neutralization of endogenous APRIL was able to dramatically reduce megakaryocyte expansion and platelet production. Thus, our data provide evidence that APRIL acts as a growth factor for terminal megakaryocytopoiesis and may promote physiologic platelet production. © 2004 by The American Society of Hematology.
Lingua originale | English |
---|---|
pagine (da-a) | 3169-3172 |
Numero di pagine | 4 |
Rivista | Blood |
Volume | 104 |
DOI | |
Stato di pubblicazione | Pubblicato - 2004 |
Keywords
- Autocrine Communication
- Blood Platelets
- Cell Division
- Fetal Blood
- Growth Substances
- Hematology
- Humans
- Megakaryocytes
- Nuclear Proteins